News

September 14, 1998 Company invests heavily in R&D and core technologies Source: Chemical Market Reporter New York-based Kyowa Hakko USA, Inc. is profiting from strong demand in the amino acids market, which reflects the vigorous performance of the US health food, nutrition, pharmaceuticals and fine chemicals industries. Kyowa Hakko USA, the marketing arm of Tokyo, Japan based Kyowa Kogyo Company Ltd., is supplying an increasing range of its amino acid products to the US pharmaceuticals and fine chemicals market. The strength of the chirals market is another driving force in the growth...

September 14, 1998 Source: Chemical Market Reporter Construction will begin shortly on a $50 million plant in Girardeau, MO., to manufacture nucleotide seasonings for the newly formed company Kyowa Foods, Inc. The groundbreaking is expected to take place in November. The plant will have a capacity of 2,000 metric tons and employ 50 to 60 people. Nucleotides are already being produced in Japan by Kyowa Hakko Kogyo Company, Ltd., which has exported them globally for the past 10 years. The output of the new plant will double Kyowa's capacity and position it for the expected growth in the s...

A vitamin-like substance found in every cell in the body may hold the answer to preventing heart disease.

June 1, 1998 Source: North American Precise Syndicate, Inc. (NAPS) - A vitamin-like substance found in every cell in the body may hold the answer to preventing heart disease. Naturally present in small amounts in a wide variety of foods, CoEnzyme Q10 plays an important part in the body's production of energy. This year scientists from all over the world attended the first International CoQ10 Conference in Boston. Scientific sessions from May 21 to 24 discussed clinical studies that have demonstrated the supplement's positive impact on heart disease and aging, among other problems. ...